REFRACTORY GRADE 3 FOLLICULAR LYMPHOMA

Clinical trials for REFRACTORY GRADE 3 FOLLICULAR LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY GRADE 3 FOLLICULAR LYMPHOMA trials appear

Sign up with your email to follow new studies for REFRACTORY GRADE 3 FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Scientists test new combo attack on stubborn blood cancers

Disease control Completed

This early-stage study tested a new combination of two drugs, lenalidomide and blinatumomab, for people with non-Hodgkin lymphoma that had come back or stopped responding to other treatments. The main goal was to find the safest and most effective dose of the drugs when used toge…

Matched conditions: REFRACTORY GRADE 3 FOLLICULAR LYMPHOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC

REFRACTORY GRADE 3 FOLLICULAR LYMPHOMA

Get alerted when new REFRACTORY GRADE 3 FOLLICULAR LYMPHOMA trials appear

Scientists test new combo attack on stubborn blood cancers